Novo Holdings' $16.5 billion acquisition of US contract development and manufacturing organisation (CDMO) Catalent has been completed, after months of debate over potential antitrust issues.

The deal adds to a rapidly-expanding pipeline of NASH candidates at Novo Nordisk, which also includes GLP-1 analogue semaglutide in phase 3 in combination with drugs from Gilead, a long-acting ...

The selling prices in wholesale trade were 0.9% higher in January 2025 than in January 2024. Compared with the same month a year earlier, the rate of change was +0.1% in December 2024, and -0.6% in ...

Biosynthesis can be exploited for chemical synthesis in vitro or in cells like Escherichia coli by combining substrates with enzymes using recombinant methods. Medium- and branched-chain diols and ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

After hours: 7:59:01 p.m. EST ...

We introduce Sana, a text-to-image framework that can efficiently generate images up to 4096 × 4096 resolution. Sana can synthesize high-resolution, high-quality images with strong text-image ...